Dora Balogh, Technical University of Munich (TUM) (IMAGE)
Caption
The proteolytic enzyme ClpP plays an important role in bacterial metabolism and ensures the controlled degradation of defective proteins. It is therefore a particularly promising point of attack for future antibacterial therapies. Dora Balogh, member of the research group of Prof. Dr. Stephan Sieber at the Technical University of Munich, managed to produce and stabilize the ClpX-ClpP complex for the first time.
Credit
Andreas Battenberg / TUM
Usage Restrictions
None
License
Licensed content